TITLE

Bernadine P. Healy

PUB. DATE
October 2011
SOURCE
H&HN: Hospitals & Health Networks;Oct2011, Vol. 85 Issue 10, p62
SOURCE TYPE
Trade Publication
DOC. TYPE
Obituary
ABSTRACT
The article presents an obituary for Bernadine P. Healy, the former director of the U.S. National Institute of Health.
ACCESSION #
67001805

 

Related Articles

  • Committee Recommends Against Complete NIH Reorganization. Marwick, Charles // JNCI: Journal of the National Cancer Institute;9/3/2003, Vol. 95 Issue 17, p1271 

    Presents the recommendations of a 21-member committee of the National Research Council and the Institute of Medicine concerning the National Institutes of Health's (NIH) reorganization. Duties of the NIH director; Term of the NIH director; Formation of a National Center for Clinical Research...

  • National Institutes of Health Releases New Guidelines on Human Stem Cell Research. Williams, David A. // Molecular Therapy;Sep2009, Vol. 17 Issue 9, p1485 

    The article presents the guidelines Removing Barriers to Responsible Scientific Research Involving Human Stem Cells by the National Institutes of Health (NIH) in response to President Barack Obama's Executive Order on March 9, 2009 in the U.S. The guidelines were issued after publication in the...

  • Creating change on a broader scale. Daniel-Burke, Rebecca // Counseling Today;Feb2013, Vol. 55 Issue 8, p18 

    An interview with Brittany Sansbury, executive at the National Institutes of Health (NIS), is presented. When asked about the tasks she performs at NIS, she says that she investigates psychological factors associated with medication adherence. She states that she served as a doctoral intern at a...

  • NIH Forms New Program for Mysterious Diseases.  // Bioworld Week;5/26/2008, Vol. 16 Issue 21, p3 

    The article reports on the joint venture by the three programs of the National Institutes of Health (NIH) to diagnos patients with ailments that have flumoxed their physicians and eluded diagnosis in the U.S. Elias Zerhouni, director of NIH, states that the initiative which is called Undiagnosed...

  • Varmus bows out. Birmingham, Karen // Nature Medicine;Nov99, Vol. 5 Issue 11, p1219 

    Reports on the resignation of U.S. National Institutes of Health director Harold Varmus.

  • Found in translation. Shaywitz, David; Dansky, Hayes // Nature Biotechnology;May2007, Vol. 25 Issue 5, p601 

    The article focuses on the need to develop and support translational researchers in the U.S. According to Elias Zerhouni, National Institutes of Health (NIH) director, the recruiting, mentoring, training and retaining of translational scientists is getting more and more difficult each year. He...

  • Research policy: The map man. Wadman, Meredith // Nature;7/26/2007, Vol. 448 Issue 7152, p406 

    The article focuses on Alan Krensky, the deputy director of the Office of Portfolio Analysis and Strategic Initiatives (OPASI) of the National Institutes of Health (NIH) in the U.S. Krensky is a respected pediatric immunologist at Stanford University and has been recruited to institutionalize...

  • THE WEALTHY CATALYST. HAMILTON, TYLER // Corporate Knights Magazine;Winter2013, Vol. 11 Issue 4, p46 

    An interview with Lindy Fishburne, executive director of Breakout Labs, is presented. She explains the reason for the establishment of Breakout Labs. She offers her insights about the funding of the U.S. National Institutes of Health. She provides her opinion on the involvement of billionaires...

  • News Briefs.  // American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1798 

    The article offers news briefs in the U.S. for various topics including the approval of the U.S. Food & Drugs Administration (FDA) on the Levothroid brand of levothyroxine distributed by Forest Pharmaceuticals Inc., the appointment of William M. Ellis as the executive director of the Board of...

  • Kenneth Olden, Master Fencer. Brown, Valerie J. // American Journal of Public Health;Nov2004, Vol. 94 Issue 11, p1905 

    This article looks at the contributions of Kenneth Olden, director of the National Institute of Environmental Health Sciences (NIEHS)and the National Toxicology Program of the U.S. National Institutes of Health (NIH), to public health. When Dr. Kenneth Olden steps down this 2004 from his...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics